⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for neoplasms, pulmonary

Every month we try and update this database with for neoplasms, pulmonary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerNCT01090830
Non-Small-Cell ...
Belinostat, car...
18 Years - Holy Cross Hospital, Florida
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaNCT02549638
Carcinoma, Squa...
Carcinoma, Squa...
Squamous Cell C...
Lung Neoplasms
Cancer of Lung
Cancer of the L...
Lung Cancer
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
DNA Extraction
18 Years - Mayo Clinic
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerNCT01090830
Non-Small-Cell ...
Belinostat, car...
18 Years - Holy Cross Hospital, Florida
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung CancerNCT02410603
Lung Cancer
Lung Neoplasms
Cancer of Lung
Cancer of the L...
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
Carcinoma, Non-...
Adenocarcinoma
Squamous Cell C...
18 Years - Mayo Clinic
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)NCT03157128
Non-Small Cell ...
Medullary Thyro...
Colon Cancer
Any Solid Tumor
LOXO-292
12 Years - Eli Lilly and Company
A Phase I Study of iPS Cell Generation From Patients With COPDNCT01860898
Thoracic Diseas...
Respiratory Tra...
Cancer of Lung
Cancer of the L...
Lung Cancer
Lung Diseases, ...
COPD
Pulmonary Emphy...
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
Carcinoma, Non-...
Carcinoma, Smal...
Skin Biopsy
18 Years - Mayo Clinic
A Phase I Study of iPS Cell Generation From Patients With COPDNCT01860898
Thoracic Diseas...
Respiratory Tra...
Cancer of Lung
Cancer of the L...
Lung Cancer
Lung Diseases, ...
COPD
Pulmonary Emphy...
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
Carcinoma, Non-...
Carcinoma, Smal...
Skin Biopsy
18 Years - Mayo Clinic
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaNCT02549638
Carcinoma, Squa...
Carcinoma, Squa...
Squamous Cell C...
Lung Neoplasms
Cancer of Lung
Cancer of the L...
Lung Cancer
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
DNA Extraction
18 Years - Mayo Clinic
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ SystemNCT02370303
Lung Cancer
Lung Neoplasms
Cancer of Lung
Cancer of the L...
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
Carcinoma, Non-...
Adenocarcinoma
Squamous Cell C...
18 Years - Mayo Clinic
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ SystemNCT02370303
Lung Cancer
Lung Neoplasms
Cancer of Lung
Cancer of the L...
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
Carcinoma, Non-...
Adenocarcinoma
Squamous Cell C...
18 Years - Mayo Clinic
Breath Test for Early Detection of Lung CancerNCT00639067
Lung Neoplasms
Breath Collecti...
18 Years - Menssana Research, Inc.
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerNCT05132075
Non-Small Cell ...
JDQ443
docetaxel
18 Years - Novartis
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsNCT03899792
Medullary Thyro...
Infantile Myofi...
Infantile Fibro...
Papillary Thyro...
Soft Tissue Sar...
LOXO-292
6 Months - 21 YearsEli Lilly and Company
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsNCT03899792
Medullary Thyro...
Infantile Myofi...
Infantile Fibro...
Papillary Thyro...
Soft Tissue Sar...
LOXO-292
6 Months - 21 YearsEli Lilly and Company
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerNCT05132075
Non-Small Cell ...
JDQ443
docetaxel
18 Years - Novartis
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyNCT00290017
Carcinoma, Non-...
Lung Cancer
Neoplasms, Lung
Neoplasms, Pulm...
talabostat
pemetrexed
18 Years - Point Therapeutics
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)NCT02673021
Lung Neoplasms
Cancer of Lung
Cancer of the L...
Lung Cancer
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
Metastatic Canc...
Microwave ablat...
18 Years - Mayo Clinic
Breath Test for Early Detection of Lung CancerNCT00639067
Lung Neoplasms
Breath Collecti...
18 Years - Menssana Research, Inc.
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationNCT04699188
KRAS G12C Mutan...
Carcinoma, Non-...
Carcinoma, Colo...
Cancer of Lung
Cancer of the L...
Lung Cancer
Neoplasms, Lung
Neoplasms, Pulm...
Pulmonary Cance...
Pulmonary Neopl...
JDQ443
TNO155
tislelizumab
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: